Edition:
India

AngioDynamics Inc (ANGO.OQ)

ANGO.OQ on NASDAQ Stock Exchange Global Select Market

20.23USD
18 Apr 2019
Change (% chg)

$-1.08 (-5.07%)
Prev Close
$21.31
Open
$19.25
Day's High
$20.72
Day's Low
$19.02
Volume
175,299
Avg. Vol
83,569
52-wk High
$25.45
52-wk Low
$18.60

Latest Key Developments (Source: Significant Developments)

AngioDynamics Reports Q3 Adjusted Earnings Per Share $0.19
Tuesday, 2 Apr 2019 

April 2 (Reuters) - AngioDynamics Inc ::ANGIODYNAMICS REPORTS FISCAL 2019 THIRD QUARTER FINANCIAL RESULTS.Q3 ADJUSTED EARNINGS PER SHARE $0.19.Q3 GAAP EARNINGS PER SHARE $0.02.Q3 SALES $86.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $88.3 MILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.22 -- REFINITIV IBES DATA.SEES FY 2019 SALES $354 MILLION TO $359 MILLION.SEES 2019 ADJUSTED EARNINGS PER SHARE IN RANGE OF $0.82 TO $0.86.RECEIVED UNCONDITIONAL IDE APPROVAL FROM FDA TO INITIATE NANOKNIFE DIRECT CLINICAL STUDY.  Full Article

AngioDynamics Reports Q2 EPS of $0.06
Friday, 4 Jan 2019 

Jan 4 (Reuters) - AngioDynamics Inc ::ANGIODYNAMICS REPORTS FISCAL 2019 SECOND QUARTER FINANCIAL RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.22.Q2 GAAP EARNINGS PER SHARE $0.06.Q2 SALES $91.5 MILLION VERSUS REFINITIV IBES ESTIMATE OF $89.2 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.21 -- REFINITIV IBES DATA.SEES FY 2019 SALES $354 MILLION TO $359 MILLION.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $0.82 TO $0.86.FY2019 EARNINGS PER SHARE VIEW $0.84, REVENUE VIEW $356.1 MILLION -- REFINITIV IBES DATA.  Full Article

Angiodynamics To Acquire Radiadyne
Thursday, 13 Sep 2018 

Sept 13 (Reuters) - AngioDynamics Inc ::ANGIODYNAMICS TO ACQUIRE RADIADYNE AND ITS REVOLUTIONARY OARTRAC® RADIATION DOSE MONITORING PLATFORM TO FURTHER EXPAND ONCOLOGY PORTFOLIO.ANGIODYNAMICS INC - ACQUISITION IS EXPECTED BE NEUTRAL TO EARNINGS ON AN ADJUSTED BASIS.  Full Article

AngioDynamics Announced Acquisition Of Biosentry Tract Sealant System Technology
Wednesday, 15 Aug 2018 

Aug 15 (Reuters) - AngioDynamics Inc ::ANGIODYNAMICS PROVIDES UPDATES ON ONCOLOGY AND VASCULAR ACCESS BUSINESSES.ANGIODYNAMICS - ANNOUNCED ACQUISITION OF BIOSENTRY TRACT SEALANT SYSTEM TECHNOLOGY FROM SURGICAL SPECIALTIES LLC.ANGIODYNAMICS INC - ACQUISITION IS EXPECTED TO BE NEUTRAL TO EARNINGS ON AN ADJUSTED BASIS.ANGIODYNAMICS - ON AUG. 6, A U.S. COURT REJECTED - IN ITS ENTIRETY - C.R. BARD'S MOTION TO DISMISS CO'S LAWSUIT FILED IN MAY 2017 AGAINST BARD.ANGIODYNAMICS - CO'S ANTITRUST LAWSUIT AGAINST C.R. BARD WILL PROCEED.  Full Article

Angiodynamics Reports Fiscal 2018 Fourth Quarter Results
Wednesday, 11 Jul 2018 

July 11 (Reuters) - AngioDynamics Inc ::ANGIODYNAMICS REPORTS FISCAL 2018 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $0.20.Q4 GAAP EARNINGS PER SHARE $0.06.SEES FY 2019 SALES $344 MILLION TO $349 MILLION.Q4 SALES $88.3 MILLION VERSUS I/B/E/S VIEW $89.3 MILLION.Q4 EARNINGS PER SHARE VIEW $0.21 -- THOMSON REUTERS I/B/E/S.SEES FY 2019 ADJUSTED EARNINGS PER SHARE $0.82 TO $0.86.ANGIODYNAMICS SEES FY 2019 FREE CASH FLOW OF $38 TO $43 MILLION, EXCLUDING ABOUT $12.5 MILLION CASH PAYMENT TO DOJ RELATED TO PRIOR DISCLOSED LEGAL MATTERS.  Full Article

AngioDynamics Says U.S. Tax Reform To Have Impact Of $0.02- $0.04 On Non-GAAP Adjusted EPS In FY 2018
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - AngioDynamics Inc ::ANGIODYNAMICS SAYS U.S. TAX REFORM ACT TO HAVE AN IMPACT IN RANGE OF $0.02- $0.04 ON NON-GAAP ADJUSTED EPS IN FY 2018 -SEC FILING.  Full Article

AngioDynamics Q2 GAAP Earnings Per Share $0.01
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - AngioDynamics Inc ::ANGIODYNAMICS REPORTS FISCAL 2018 SECOND QUARTER FINANCIAL RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.16.Q2 GAAP EARNINGS PER SHARE $0.01.SEES FY 2018 SALES $345 MILLION TO $350 MILLION.Q2 SALES $86.7 MILLION VERSUS I/B/E/S VIEW $88.4 MILLION.Q2 EARNINGS PER SHARE VIEW $0.16 -- THOMSON REUTERS I/B/E/S.REAFFIRMS FY 2018 ADJUSTED EARNINGS PER SHARE VIEW $0.64 TO $0.68 EXCLUDING ITEMS.FOR 2018, COMPANY IS REDUCING ITS PREVIOUSLY ANNOUNCED NET SALES AND FREE CASH FLOW GUIDANCE.CO NOW EXPECTS ITS FISCAL YEAR 2018 NET SALES IN RANGE OF $345 TO $350 MILLION.  Full Article

AngioDynamics reports fiscal 2018 first quarter results
Thursday, 28 Sep 2017 

Sept 28 (Reuters) - AngioDynamics Inc :AngioDynamics reports fiscal 2018 first quarter results.Q1 adjusted non-GAAP earnings per share $0.12 excluding items.Q1 earnings per share $0.00.Q1 sales $85.4 million versus I/B/E/S view $86.1 million.Q1 earnings per share view $0.16 -- Thomson Reuters I/B/E/S.Reaffirms FY 2018 adjusted earnings per share view $0.64 to $0.68.Sees FY 2018 sales $352 million to $359 million.FY2018 earnings per share view $0.67, revenue view $354.8 million -- Thomson Reuters I/B/E/S.  Full Article

AngioDynamics reports Q4 loss per share $0.30
Tuesday, 18 Jul 2017 

July 18 (Reuters) - Angiodynamics Inc :Reports FY 2017 GAAP EPS of $0.19; adjusted EPS of $0.73, up 22% compared to FY2016​.Angiodynamics reports fiscal 2017 fourth quarter and full-year results.Q4 adjusted non-gaap earnings per share $0.19 excluding items.Q4 loss per share $0.30.Q4 sales $86.9 million versus i/b/e/s view $90.7 million.Q4 earnings per share view $0.16 -- Thomson Reuters I/B/E/S.Angiodynamics inc says issued its fy2018 financial guidance affirming a net sales range of $352 to $359 million.Sees fy 2018 adjusted earnings per share $0.64 to $0.68.Fy2018 earnings per share view $0.68, revenue view $357.3 million -- Thomson Reuters I/B/E/S.  Full Article

AngioDynamics lawsuit claims C.R. Bard is violating antitrust laws, harming competition, limiting access
Wednesday, 31 May 2017 

May 31 (Reuters) - AngioDynamics Inc ::AngioDynamics - "C.R. Bard has illegally tied sale of tip location systems to line of peripherally inserted central catheters," as per lawsuit filed by co.AngioDynamics - lawsuit claims that C.R. Bard will only sell proprietary stylet necessary to operate its tip location systems preloaded in its PICCs.  Full Article